US 12097188
Compositions and methods for the treatment of macular degeneration
granted A61KA61K31/423A61K31/47
Quick answer
US patent 12097188 (Compositions and methods for the treatment of macular degeneration) held by Aldeyra Therapeutics, Inc. expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aldeyra Therapeutics, Inc.
- Grant date
- Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/423, A61K31/47, A61K47/40, A61K9/0048